Beximco Pharmaceuticals PLC.

62.50pAs of Sun 8 Nov 2026, 12:00 UTC

LSE:BXPHealthcare

Ctry United Kingdom

PE (Fwd) 4.594

TSR 10Y CAGR 3.49%

Div yield —

ROE 14.40%

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.28

PE TTM 5.238

TSR TTM 45.46%

Mkt cap £278.8M

ROIC 19.48%

SE Grade™

Value

Quality

Moat

1Y Price

Reference

76p

21.43%

6.51%

Price near Reference Value

TTM

FYE 30 Jun BDT

FY2022

FY2023

FY2024

FY2025

FY2026E

FY2027E

Trend

10Y

Peers

53.93

RevenueBDT B

—

34.67

39.27

44.39

49.12

55.46

61.99

12.32%

—

Revenue growth%

—

13.26

13.05

10.65

12.90

—

13.05

—

47.86

Gross margin%

—

45.63

44.07

44.23

45.39

47.84

47.79

44.81

—

21.31

Operating margin%

—

19.75

18.27

19.35

19.58

21.29

21.25

19.47

—

16.04

Net margin%

—

14.78

11.75

13.13

14.13

16.00

15.91

13.63

—

5.238

P/E ratio (avg)x

—

9.378

5.963

4.170

2.908

5.105

4.594

5.066

—

4.069

EV/EBITx

—

8.654

5.156

3.432

2.438

3.597

2.621

4.294

—

100

15.18

FCF yield (avg)%

—

4.73

12.27

25.22

20.78

15.64

17.57

16.52

—

12.75

FCF margin%

—

6.56

8.59

13.81

8.54

12.77

12.84

8.57

—

0.795

FCF / Net incomex

—

0.444

0.731

1.052

0.604

0.798

0.807

0.668

—

19.48

ROIC%

—

13.22

13.67

16.16

17.57

19.95

21.81

14.92

—

14.40

Return on equity%

—

12.62

10.95

12.72

13.74

14.51

14.68

12.67

—

10.99

Return on assets%

—

7.74

6.67

8.41

9.48

10.96

10.86

8.08

—

19.39

EPSBDT

—

11.48

10.34

13.07

15.56

19.89

22.11

10.66%

—

EPS growth%

—

(9.93)

26.38

19.06

27.87

11.11

19.06

—

134.60

Bookvalue per shBDT

—

90.98

97.89

107.48

119.04

139.56

161.67

9.38%

—

15.41

FCF per shareBDT

—

5.10

7.56

13.74

9.40

15.88

17.84

22.63%

—

Dividend per shBDT

—

Div yield (avg)%

—

Payout ratio%

—

446.1

Shares (diluted)M

—

446.3

446.2

446.1

◌446.1

(0.01%)

—

Buyback yield%

—

0.01

0.03

—

◌—

0.01

—

0.053

D/E ratiox

—

0.305

0.243

0.126

0.094

0.051

0.044

0.184

—

46.77

Enterprise valueBDT B

—

59.25

36.99

29.48

23.45

42.48

34.52

(26.58%)

—

1.090

LT debtBDT B

—

2.997

2.158

1.433

1.202

1.090

(26.26%)

—

Peers (US$520.6M)

Cap (US$)

Qianjiang Yongan…

524.0M

31.37x

Newland Pharmaceutical…

523.1M

37.33x

Henan Taloph Pharmaceu…

523.0M

70.32x

Shandong Wohua…

518.3M

27.02x

Capital

TTM

10Y

Leveragex

(0.083)

0.757

EBIT/Intx

16.87

7.529

Own earn%

—

Sh yield%

—

0.01

Owners

Insiders/Inst%

—

0.08

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

4/4

Revenue growth years

3/3

EPS growth years

2/3

Dividend streakyrs

Op margin range%

18–20

$1 testx

−1.6

Incr. ROIC%

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

BDT 49.12B

12.32%

1.00×

Cost of revenue

BDT 26.82B

12.48%

1.00×

Operating expenses

BDT 12.68B

12.20%

1.00×

Asset mix

Trend

Other

90.35%

Goodwill & intangibles

7.33%

Cash and investments

2.32%

Reinvestment returns

4Y median

Trend

Reinvestment rate

9.79%

Return on capital

14.92%

Spread over hurdle

(5.88%)